Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel …
U Goerling, T Gauler, A Dietz, V Grünwald… - Oncology Research …, 2022 - karger.com
Introduction: CeFCiD was a multicenter phase II study comparing the efficacy of cetuximab
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
[引用][C] Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and …
U Goerling, T Gauler, A Dietz… - Oncology Research …, 2022 - ub01.uni-tuebingen.de
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil,
Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the …
Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the …
[引用][C] Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and …
U Goerling, T Gauler, A Dietz… - Oncology …, 2022 - tobias-lib.ub.uni-tuebingen.de
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil,
Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the …
Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel within the …
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel …
U Goerling, T Gauler, A Dietz, V Grünwald… - Oncology Research …, 2021 - europepmc.org
Methods The European Organization for Research and Treatment of Cancer Quality of life
Questionnaire QLQ-C30 and the tumor-specific module for head and neck cancer (QLQ …
Questionnaire QLQ-C30 and the tumor-specific module for head and neck cancer (QLQ …
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel …
U Goerling, T Gauler, A Dietz, V Grünwald… - Oncology Research …, 2022 - karger.com
Introduction: CeFCiD was a multicenter phase II study comparing the efficacy of cetuximab
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel …
U Goerling, T Gauler, A Dietz… - Oncology Research …, 2022 - search.ebscohost.com
Introduction: CeFCiD was a multicenter phase II study comparing the efficacy of cetuximab
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel …
U Goerling, T Gauler, A Dietz… - Oncology research …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction CeFCiD was a multicenter phase II study comparing the efficacy of cetuximab
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
Quality of Life of Patients with Head and Neck Cancer Receiving Cetuximab, Fluorouracil, Cisplatin Comparing to Cetuximab, Fluorouracil, Cisplatin, and Docetaxel …
U Goerling, T Gauler, A Dietz… - Oncology Research …, 2021 - refubium.fu-berlin.de
Introduction: CeFCiD was a multicenter phase II study comparing the efficacy of cetuximab
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …
(C), 5-flourouracil, and cisplatin with the same regimen adding docetaxel (D) in …